Smart science to improve lives™
Open search Basket 0 View basket

Speak with an expert


A novel liposomal adjuvant used in cancer immunotherapy trials, CAF09b has the capacity to facilitate the production of CD8+ T-cells.

indicates required field
Please provide your first name
Please provide your last name
Please provide an email address
Please provide your company name
Please complete the recaptcha and resubmit the form.